Embla Medical hf (OTCPK:OSSFF)
$ 5.175 0 (0%) Market Cap: 2.10 Bil Enterprise Value: 2.56 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 81/100

Q3 2019 Ossur hf Earnings Call Transcript

Oct 22, 2019 / 07:00AM GMT
Release Date Price: $6.9
Operator

Ladies and gentlemen, welcome to the Ãssur's Q3 Results 2019. Today, I am pleased to present Mr. Jón Sigurdsson, President and CEO; and Mr. Sveinn Sölvason, CFO. (Operator Instructions)

Mr. Sigurdsson and Mr. Sölvason, please begin.

Jón Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thank you very much. I would also like to welcome you to the Ãssur investor conference call where we will cover the results for the third quarter of 2019. As previously mentioned, my name is Jón Sigurdsson, and I'm the President and CEO, and with me here today is Sveinn Sölvason, our CFO. I will start by going through the highlights of the quarter and end with our guidance for 2019. A question-and-answer session will then follow.

Sales in the third quarter of the year amounted to $168 million, corresponding to 19% growth in local currency, 5% organic growth and 15% reported growth in U.S. dollars. In the first 9 months of the year, local currency growth amounted to 19% and organic growth was 7%. EBITDA before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot